Evidence map›Paper›PMID 32555145›Full record

ArticleSignal transduction and targeted therapy2020

Targeting the entry step of SARS-CoV-2: a promising therapeutic approach.

Jing Li, Peng Zhan, Xinyong Liu

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Signal transduction and targeted therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. International journal of molecular sciences · 2021
    Article
  9. Article
  10. ViralFP: A Web Application of Viral Fusion Proteins.Frontiers in medical technology · 2021
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jing LiDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Ji'nan, 250012, China.
Peng ZhanDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Ji'nan, 250012, China. zhanpeng1982@sdu.edu.cn.
Xinyong LiuDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Ji'nan, 250012, China. xinyongl@sdu.edu.cn.

Funding

National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) No. 81420108027
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Severe acute respiratory syndrome-related coronavirusBetacoronavirusCoronavirus InfectionsCOVID-19HumansPandemicsPeptidyl-Dipeptidase APneumonia, ViralProtease InhibitorsSARS-CoV-2Virus InternalizationPeptidyl-Dipeptidase AProtease Inhibitors

Identifiers

PMID32555145
PMCPMC7298436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.